Purdue University

Purdue e-Pubs
Purdue University Libraries Open Access
Publishing Support Fund

Purdue Libraries and School of Information
Studies

3-30-2022

Hormonal male contraception: Formative research to develop and
test communication messaging
Jaziel Ramos-Ortiz
Purdue University, jlortiz0214@gmail.com

Hannah King
Purdue University

Andrea L. DeMaria
Purdue University

Follow this and additional works at: https://docs.lib.purdue.edu/fund

Recommended Citation
Ramos-Ortiz J, King H, DeMaria AL. Hormonal Male Contraception: Formative Research to Develop and
Test Communication Messaging. American Journal of Men’s Health. May 2022. doi:10.1177/
15579883221094702

This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries.
Please contact epubs@purdue.edu for additional information.

1094702
research-article2022

JMHXXX10.1177/15579883221094702American Journal of Men’s HealthRamos-Ortiz et al.

Special Collection: Male Sexual and Reproductive Health - Original Article

Hormonal Male Contraception:
Formative Research to Develop and
Test Communication Messaging

American Journal of Men’s Health
May-June 1–12
© The Author(s) 2022
Article reuse guidelines:
sagepub.com/journals-permissions
https://doi.org/10.1177/15579883221094702
DOI: 10.1177/15579883221094702
journals.sagepub.com/home/jmh

Jaziel Ramos-Ortiz1, Hannah King2, and Andrea L. DeMaria2

Abstract
Male-controlled contraception is limited, yet a promising hormonal male contraceptive (HMC) development in
may increase options for men to share in the work of pregnancy prevention. This study examined college-aged
(18–26 years) men’s and women’s perceptions of influential marketing strategy for an experimental novel HMC
method, a transdermal gel. Six focus groups (n = 29) were conducted to glean insights for ad prototype creation.
Ad prototypes were designed and then tested in semi-structured interviews (n = 20) to understand whether the
messages were adequately representing the attributes intended while also allowing participants to contribute insights
on improving appeal. A constant comparative approach was used for data contextualization and theme identification.
Results provided a foundation for the creation of HMC message prototypes, aimed at increasing knowledge and
uptake of a novel family planning method for men. Representation of a relatable character, or drawing on authentic
experiences, aligned best with participant values. Focus groups illuminated salient concepts for HMC marketing,
including humor, destigmatization, information, and credibility. Interview message testing yielded an understanding of
elements participants responded most strongly to, including (1) ad sentiment and (2) trustworthiness. Findings provide
a basis for understanding the placement of a potential marketing campaign to effectively frame HMC uptake as easy
to use, safe, and popular while building on peer norms and group acceptability among a college-aged demographic.
Healthcare providers and other practitioners can utilize these findings while engaging in family planning conversations,
interventions, and message development.
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Introduction
In October 2018, a novel reversible hormonal male contraceptive (HMC) gel entered Phase 2 clinical trials
(NICHD, 2021; NIH, 2018), a promising development
that may soon impact the lives of reproductive-aged men
and women. Until the mid-to-late-2010s, male-controlled
contraceptive options had not seen significant developments for over a century, limiting available methods to
the male condom and vasectomy (Lloyd & Waterfield,
2016). Advances in the last 5 years (Anawalt et al., 2019;
Behre et al., 2016; Wang et al., 2016) suggest HMC as a
prospective pregnancy prevention tool. With approximately half of all pregnancies in the United States
reported as unintended (Guttmacher Institute, 2019), and

despite innovations in the accessibility of hormonal
female contraceptive (HFC) methods, alternative developments, such as male-controlled options, must continue
to be explored.
Despite extensive research and developments
(Anawalt et al., 2019; Kuo, 2010; Mullin, 2018; NICHD,
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2021; Nieschlag & Henke, 2005; Roth et al., 2014;
Surampudi et al., 2014), barriers to HMC persist; side
effect concerns, biological difficulties in the efficacy of
sperm suppression, and cost/benefit debates all contribute to HMC delays. Funding is limited as the potential
risks of HMC (i.e., efficacy, side effects, and litigation
concerns) are perceived as outweighing benefits, even
with potential positive outcomes (Anthes, 2017).
Furthermore, when compared with existing HFC
options, the payoff for investing in HMC remains in
question (Lissner, 2017). This demonstrates a need to
explore marketability to understand the costs, benefits,
and consumer needs.

Existing Attitudes and Perceptions Toward
HMC
Men. Understanding existing attitudes and perceptions
toward the prospect of HMC also offers insight into barriers and facilitators to uptake, by incorporating target
market perspectives. Prior literature (Glasier, 2010;
Heinemann et al., 2005; Mullin, 2018) suggests men
exhibit a general willingness to assume contraceptive
responsibility, if available, given its proposed effectiveness in pregnancy prevention and increased comfort in
having backup protection (Glasier, 2010). Shifts in contraceptive responsibility (Dismore et al., 2016; Lloyd &
Waterfield, 2016; Sax et al., 2019), increased opportunities for reproductive autonomy (Dismore et al., 2016;
Walker, 2011), and potential distrust of casual female
partners (Glasier et al., 2000; Lloyd & Waterfield, 2016)
have all been cited as reasons for male acceptability of
HMC. Preference for male condoms, the inability to protect against sexually transmitted infections (STIs; Walker,
2011), and side effect concerns (Dismore et al., 2016)
contribute to HMC resistance.
Women. Partner influence in contraceptive choice is
important, as men’s perceptions of female contraceptive behaviors have been shown to affect decisionmaking (Dudgeon & Inhorn, 2004; George et al.,
2019). Understanding the potential female influence
on HMC decision-making among men and incorporating this in messaging strategy may also enhance HMC
messaging efficacy and adoption. Women’s attitudes
toward HMC are generally positive; however, many
express concern surrounding a male partner’s ability to
employ perfect use (Eberhardt et al., 2009; Marcell
et al., 2005) and men disregarding male condom use,
leading to STI increases (Dismore et al., 2016). Extant
literature shows a public interest in HMC, warranting
the need to prioritize market research as that potential
grows nearer.
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HMC Promotion Considerations
Marketing must address HMC perceptions from both
male and female perspectives, especially within the college-aged demographic, as unintended pregnancies are
common and can potentially contribute to delaying or
derailing educational plans. Among college men, knowledge about existing contraception is limited (Borrero
et al., 2013; George et al., 2019; Gollub et al., 2020),
despite men citing fear of unintended pregnancy as motivation for prevention (Gollub et al., 2020). This presents
an opportunity to assess contraceptive misconceptions
and understand attitudes before a male option is available
to inform an effective messaging strategy. HMC remains,
essentially, a novel product, indicating additional strategic measures must be taken to effectively promote HMC
uptake. Investigating the perspectives and interest of a
novel health product like HMC (Truong & Dang, 2017)
coupled with formative market research methodologies
(Truong & Dang, 2017), may be well-positioned to
inform the effective promotion and uptake of HMC.
The current study consists of two phases, aimed first
at developing ad prototypes via focus groups, followed
by testing these prototypes via individual in-depth interviews. This combination of methodologies allowed for
the collection of interpretations emerging in group and
individual settings surrounding existing male contraceptive methods, prospective HMC options, and HMC marketing strategy recommendations. Purdue University’s
institutional review board approved the study (IRB2019-384). The Methods and Results are organized by
phase.

Method: Phase 1
Researchers followed recommendations in past methodological literature regarding the number of focus groups
necessary for explanatory power to achieve theoretical
saturation (Carlsen & Glenton, 2011; Guest et al., 2017).
A review examining focus group sampling found that
approximately 80% of themes are discovered within the
first two to three focus groups and 90% were discovered
between three and six focus groups (Guest et al., 2017).
Participants for male focus groups were recruited via targeted e-mail communication, filtered to only include
male undergraduate students, and aged 18 to 26, who
attended the university at the time of the study. The
recruitment email discussed the study purpose and focus
group schedule process, including locations and duration.
Participant availability during one of the three provided
times served as an additional eligibility criterion. Due to
negative feedback from a handful of male students disagreeing with the study’s focus on male contraception,
in-person recruitment was employed moving forward

Ramos-Ortiz et al.
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Table 1. Focus Group Protocol.
Tell me about what you have heard about new hormonal male birth control options, if anything? (There is currently a
transdermal gel undergoing clinical trials, you may have seen articles for it on Facebook, Twitter, etc. Other clinical trials that
have occurred in the past included possibilities of an injection and a pill.)
I am going to pass out the article about the current method being tested and a sheet of paper with questions. I’ll allow you about
5 min to look it over and answer the questions.
QUESTIONS ON HANDOUT
What do you think about this? What are your immediate thoughts?
Would you consider using such a product? Why or why not?
What would prevent you from using such a product?
What would encourage you to use it?
 Take some time to think about this and write down your responses and we will share our insights with everyone after about
5 min. (After 5 min, ask the questions that were on the handout to the larger group, use whiteboard/chart paper to record
insights as participants share)
The last few things I’d like to discuss with you all have to do with f media and advertising. These questions deal with how you
prefer to receive information about new products, and what strategies are most successful at getting your attention.
With the presence of social media and other instant forms of communication, we are constantly bombarded with
advertisements, all fighting for our attention. What kinds of advertisements are usually successful at getting your attention?
Probe: What makes you notice a specific advertisement among the thousands you encounter every day?
Probe: Does where the information is coming from matter to you (i.e., social media ads, TV commercials, and billboards)?
Now, I am going to handout a question sheet and ask you to get into pairs and discuss the questions with your partner. Please
use the pen and paper provided to write down what you discuss. I will give you about 5 min to do this. (After 5 min, ask the
questions that were on the handout to the larger group, use whiteboard/chart paper to record insights as participants share)
QUESTIONS ON HANDOUT
What would you like to see in an advertisement about a new male birth control method?
What would an advertisement have to include in order to get your attention about the product?
What messages would interest you?
What about imagery?

with the female-only focus groups. This allowed the first
author to provide adequate information and clarify any
questions surrounding study scope and intent. In-person
recruitment occurred via communication with leaders
and executive members of university-sponsored organizations, such as fraternities, sororities, cultural centers,
and health-related clubs, where the first author requested
time to recruit participants at organized group meetings.
Written informed consent was collected from participants
before initiating focus group discussions. Upon focus
group completion, participants completed a brief demographic survey. Focus groups continued until theoretical
saturation was reached (Corbin & Strauss, 2008; Guest
et al., 2017), meaning all information for each question
had emerged among the focus groups held, so that any
additional data collected reinforced emergent categories,
rather than provide new information.
The first author and assistant, both female, third-year
PhD candidates at the time of the study with training in
qualitative methodology, led the male and female focus
groups, which were audio-recorded, ranging from 45 to
120 min (76.72 ± 27.81). The first author served as the
moderator, driving the discussion, while the assistant
observed, recorded, and managed tasks. Participants did
not receive a monetary incentive, but refreshments (i.e.,
pizza and soft drinks) were provided. The semi-structured

focus group protocol allowed for flexibility in adding,
editing, or modifying question order (Rubin & Rubin,
2012). This methodology also permitted participants to
introduce new, relevant concepts organically throughout
the conversation. Each discussion began by asking participants about their experiences with and knowledge of
existing male contraceptive methods. Participants read a
brief news article in conjunction with this series of questions, detailing an experimental HMC method, a transdermal gel (Anawalt et al., 2019; NICHD, 2021), and shared
immediate thoughts. Finally, participants provided recommendations surrounding effective messaging strategy.
Table 1 details the specific questions asked during the current study. About 75% of the focus group discussion duration was focused on the latter two points, as these data
were used to design the ad prototypes tested in Phase 2.

Data Analysis
Focus group audio was transcribed verbatim, and content
analysis was conducted within and across transcripts. A
constant comparison approach was used, allowing for
interpretation from within-participant words, phrases,
and overall narratives. HyperRESEARCH 4.0.1., a qualitative data management program, facilitated data organization and management. A codebook was developed
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Table 2. Participant Demographics.
(n = 49)
Demographic Categories
Age
Sex
Female
Male
Race/Ethnicity
White
Black
Hispanic/Latino
Asian/Pacific Islander
Middle Eastern/North African
Sexual orientation
Heterosexual
Bisexual
Relationship status
In an exclusive/monogamous relationship
Sexually active, but do not consider it a
relationship
Not currently sexually active with another person
Have never been sexually active with another person
Primary contraceptive methoda
Male condom
Hormonal female contraception
Withdrawal
None

M/Prop.
21.61±1.78
20 (40.82%)
29 (59.18%)
42 (85.71%)
3 (6.12%)
1 (2.04%)
2 (4.00%)
1 (2.04%)
43 (87.76%)
6 (12.24%)
22 (44.89%)
13 (26.53%)
11 (22.45%)
3 (6.12%)
19 (38.78%)
18 (36.73%)
7 (14.29%)
2 (4.08%)

Note. Results represented as M ± SD or n (%).
a
Values that do not add to sample total indicate missing data.

based on the focus group guide, initial reading results,
and existing literature consisting of keywords and phrases
extracted from participant narratives for data organization. Through open coding, keywords and phrases were
included in the codebook and attached to transcript sections based on their content (Deterding & Waters, 2018).
Initial data impressions were refined, and axial coding
began, allowing codes and categories to be compared
with overarching concepts to contextualize the data and
identify themes. This process was repeated for all focus
group transcripts.

Results: Phase 1
Overall, 3 male-only and 3 female-only focus groups
with college-aged participants (female: n = 13; male: n
= 16) were conducted. Message development results are
presented below. Quotes are marked with MFG or FFG to
indicate insights shared in either the male or the female
focus groups, respectively. Participant demographic
information is shown in Table 2.
After exposure to the HMC gel example, focus group
discussions surrounded perceptions of marketing and

messaging strategy for the product. Four themes emerged
suggesting the most salient concepts for participants were
as follows: (1) information, (2) destigmatization, (3)
humor, and (4) credibility.
Information: Learning About HMC. Participants emphasized the importance of information within a marketing
message, suggesting information as a gateway for discussion: “I think information is really good . . . you can talk
[about HMC] with your friends or your doctor. Because
it’s new, you want to have any information about it”
(MFG). Participants also discussed the importance of
straightforward, simple, honest messages: “[most ads]
are cheesy. I wouldn’t want a couple being like, ‘it worked
for us.’ I just want a picture of [the HMC method] saying,
‘hey, here it is. FDA approved. It works.’ Cool. Let’s go”
(MFG). A female participant commented on the importance of information over sentiment messages (i.e.,
humor): “[an HMC ad] probably doesn’t have to be as
funny, as [it is] informative to get the word out” (FFG).
Another participant supported this: “I think you have to
catch attention, but my eyes would look for . . . clinically
proven, tested, works this amount of the time” (FFG).
Female participants also shared ideas of effectively getting ahead of potential side effect concerns among men
via informational messaging: “[an HMC message should]
reaffirm [to men] that the testosterone won’t affect your
muscles, you won’t get emotional, don’t worry” (FFG).
Another female participant suggested that while the novelty of a potential HMC method may be enough to spark
interest, information was still key:
Honestly, [HMC ads need] to talk about what it is. Because
it’s so new, the product itself is enough for me to be curious
about it. So, I would want to [read information] about it
[being] the only [male birth control] offered right now and it
works. (FFG)

Thus, an informational, straightforward messaging strategy may counteract hesitation and circumvent side effect/
efficacy concerns.
Destigmatize: Normalizing HMC. Participants felt that
messages focused on normalizing male birth control may
contribute to destigmatizing its use: “I definitely think . .
. the biggest thing is gonna be normalizing [HMC in ads]
because it’s so new and something that guys are not used
to” (MFG). A female participant also weighed in: “I think
normalizing [HMC is important]. Sex is normal and
healthy. So, saying, ‘this doesn’t make you less of a man,
its provides an extra something to protect you’ [might
work]” (FFG). Some female participants conceptualized
destigmatization as valuing representations of real experiences. One female participant offered an example: “[the
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message should be] something relatable. Like, ‘scared
that your condom broke?’ I think most people would say,
‘yeah that happened to me!’” (FFG). Another female participant agreed:
I think of tampon commercials, the happy girl on the beach
saying, ‘I don’t have my period!’ It’s kind of off-putting, it
seems like it’s trying to be what the experience is not. I
would be more drawn to something genuine, honest, real. . .
like the person pitching it cares about how it affects
consumers. (FFG)

By highlighting the consequences of marketing messages
that downplay human experiences, this participant
stressed the importance of representing honest experiences in relatable messaging. Other female participants
suggested normalizing messages may “encourage [HMC]
as a smart choice, the smart thing to do” (FFG). Another
supported this, stating, “[an HMC message should] project that it’s enabling you to have more fun and be responsible” (FFG). Representing destigmatization as a smart
choice appeared to appeal to female participant values,
resulting in normalized feelings toward the message, and
subsequently, the product.
Humor: Captivating a Younger Audience. Humor was
described as an effective method in similar products (i.e.,
male condoms), with some participants suggesting this
could translate to HMC. One male participant offered one
example: “have you guys seen the newer Trojan commercials? They’re f**king funny. He’s holding a banana [and
putting the condom on it] that’s just funny to me, it’s silly.
[An HMC ad] needs to be along those lines” (MFG). A
female participant agreed with this, referencing the same
male condom brand appealing to the target audience
through humor: “[HMC ads should be] oriented toward a
younger crowd because sex is more fluid . . . the Trojan
condom ads are funny now, it gets the attention of younger
people” (FFG).
Participants did note instilling product trust and brand
recognition were necessary prerequisites to releasing a
humorous HMC prototype, which was why they felt ads
by the trusted condom brand were effective: “I literally
trust Trojan with my life. . . just having that brand recognition, you see that name and think, ‘hey that must work’”
(MFG). A female participant agreed, insinuating humorous message efficacy was contingent on brand trust: “if
[HMC] just jumped in right away. . . [it would not] work.
Trojan commercials are funny, but you know [the brand],
right? They can be funny because they have global recognition and trust built” (FFG). While most participants felt
humor was effective, some suggested a combination of
serious and humorous messages may better suit HMC
promotion, due to its novelty: “I think it should have a
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maturity value. It should open with some humor and go
into something a little bit more serious” (FFG). Thus,
these participants felt leveraging humor, combined with
an element of trust, may provide a unique HMC messaging opportunity.
Credibility: Reputable Sources Matter. Participants considered credibility a necessary component of HMC messaging, building upon the discussion of trust mentioned in
the aforementioned theme. A male participant explained,
“I feel like [whether you pay attention to] a product is
based on . . . credibility, not too many ads are actually
good, but if it’s credible. . . you might be more likely to
look at it” (MFG). Primarily among men, the association
of a product with a “legitimate entity” contributed to
credibility: “[if the ad] said ‘consult your primary physician’ . . . a credible source really helps, it’s trustworthy”
(MFG). Legitimate sources were also discussed as regulated or trustworthy HMC informants: “if it was a [sales]
rep . . . like a dude walking around campus that was like
‘hey, I’m here to talk about this’ . . . I would know it’s
real” (MFG).
Interestingly, while men cited legitimate sources as
physicians and sales representatives, women felt that men
would be most influenced by celebrity endorsements and
view them as credible: “if you have a well-known celebrity in the male world, that would help credibility” (FFG).
Another female participant specified, “someone like the
Rock. . . a celebrity endorsement of someone masculine”
(FFG). Male participants directly opposed this: “P1:
Yeah, I don’t care about celebrities or athletes. Or at least
guys don’t. P2: Yeah, guys don’t give a s**t. P3: I don’t
really care what you’re advertising, put points on the
board. That’s your job” (MFG). Though representing
credibility was important for both men and women, the
definition of credible, legitimate sources differed across
genders.

Method: Phase 2
The first author identified specific themes found within
the focus group data via content analysis and then broke
them down into the attributes (Table 3), following interpretation by the research team. Ad prototypes were then
designed on Canva, an online graphic design software.
The ad prototypes reflected either an informational or
colloquial message and were combined with attributes
gleaned from focus group insights relating to either message/image relatability (e.g., aspirational or realistic),
sentiment (e.g., serious or humorous), or perceived credibility (e.g., image of a doctor vs. other image). This
allowed the researchers to test appeal based on these attributes. Furthermore, participants were asked to rate how
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Table 3. Prototype Attribute Matrix.
Attribute levels
Attribute dimensions
Message strategy
Message/image relatability
Message/image sentiment
Perceived credibility

Option 1
Informational
Aspirational
Serious
Image of Doctor

informational/realistic/serious/ humorous they perceived
each message to be, on a scale of 1 to 10. Participants
were then prompted to explain their rating choices to
understand whether the messages were adequately representing the attributes intended, while also allowing participants to contribute opportunities for improvement.
Following feedback from interviews, ad prototypes were
edited to reflect interview data and were used in a later
quantitative study.
Semi-structured interviews followed the completion
of the initial focus group study. Prior studies show the
impact sexual partners, particularly men, have on contraception use (Cox et al., 2010); thus, female partners may
have a similar impact on male contraception habits due to
the higher likelihood of both partners participating in the
selection on contraceptive methods used (Heinemann
et al., 2005). Therefore, both male and female perspectives of the prototype messaging were considered.
Participants were recruited via in-person presentations
and snowball sampling, using e-mail communication if
necessary (i.e., follow-up or requested communication).
Similar to female-only focus groups, in-person recruitment occurred via communication with leaders of university-sponsored organizations, where the first author
solicited participation at organized meetings. Interested
participants scheduled their interviews after the brief talk.
Each interview lasted from 45 to 60 min (51.73 ± 10.28).
The first author conducted all interviews at a time and
place convenient to each participant. Written informed
consent was collected from participants before initiating
interviews. Upon completion of the interview, participants completed a brief demographic survey and received
a US$25.00 Amazon gift card. Interviews continued until
theoretical saturation was reached (Corbin & Strauss,
2008; Guest et al., 2006).
The semi-structured interview protocol allowed for
flexibility in moving through question order to encourage
organic introduction to relevant concepts (Rubin &
Rubin, 2012). To assess consistency across group and
individual insights, the interview inquired into similar
topics as the focus groups. In addition, the interviews
included a message testing component, where a series of
message prototypes, designed based on focus group data,
were displayed for response evaluation.

Option 2
Colloquial
Relatable
Humorous
Other image

Data Analysis
Phase 2 data were analyzed similarly to Phase 1 data.
Interview audio was transcribed verbatim, content analysis was conducted, and HyperRESEARCH 4.0.1. facilitated data organization and management. A codebook
was developed based on the interview guide, initial reading, and existing literature. For interview transcripts,
codes to sort data from the message testing component by
prototype (i.e., ratings, requested modifications) were
included. Open and axial coding were conducted, and
themes were identified. Prototype ratings (Table 4) from
the interview message testing component were also
reported, offering means and medians for each attribute
rating.

Results: Phase 2
Overall 20 college-aged participants (female: n = 7;
male: n = 13) completed interviews. Message testing
results are presented below, with FI or MI noting female
or male individual interviews. Focus group findings from
Phase 1 informed the design of the prototypes used in the
message testing component (Figure 1). In the analysis,
themes emerged related to the elements participants
responded most strongly to (1) sentiment and (2)
trustworthiness.
Sentiment: Emotional Responses to Messages. Participants
responded to message and imagery sentiments, attributing these to how the ads would make them feel about a
potential HMC product. As ads 1 (humorous) and 2 (serious) represented opposite responses to unintended pregnancy, participants evaluated the sentiments they
preferred to see in that situation. One male participant
commented on the humorous ad, stating this approach
may negatively alter his view: “[I would view HMC] a bit
negatively [because the ad] is trying to catch your attention with shock value, but it’s not something I associate
with a medical product” (MI; Ad 1). A female participant
agreed, suggesting, “a more serious route [may be more
effective for HMC] because unintended pregnancy would
be upsetting for both partners” (FI; Ad 1). A male participant echoed this: “I feel like [the serious ad] would play

Ramos-Ortiz et al.
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Table 4. Prototype Ratings.
(n = 20)
Ad
Ad 1

Ad 2

Ad 3

Ad 4

Ad 5

Ad 6

Figure 1. Ad Prototypes.

Attribute
Informational
Realistic
Humorous
Credible
Informational
Realistic
Humorous
Credible
Informational
Realistic
Humorous
Credible
Informational
Realistic
Humorous
Credible
Informational
Realistic
Humorous
Credible
Informational
Realistic
Humorous
Credible

M/Prop.

Median

2.90
5.15
7.85
3.50
3.95
7.20
1.20
5.65
5.45
7.45
2.95
6.30
4.80
7.55
3.35
5.90
9.00
8.10
1.20
8.75
4.15
6.60
1.75
6.65

2.00
5.00
8.00
3.50
4.50
7.50
1.00
6.00
6.00
8.00
2.50
7.00
4.50
8.00
4.00
7.00
9.00
8.00
1.00
9.00
4.00
6.50
1.00
7.00
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on my emotions better because this is how I would feel.
Not good, not light-hearted” (MI; Ad 2). Contrary to
some perceptions from focus groups, the humorous sentiment was not received well, confirming participants’ sentiments about brand recognition and suggesting in this
context, displaying genuine experiences on ads may be
more effective.
Trustworthiness: Character Credibility and Relatability.
Dimensions of trust and trustworthiness emerged in
participants’ prototype evaluations, particularly in the
discussion of Ads 5 and 6, both containing images of a
doctor. Aligning with credibility conversations in focus
groups, most participants favored Ad 5, referring to the
doctor image increasing credibility and trust: “I [like that
this] gives off credibility. Having a doctor. . . [shows
they’re] prescribing it or telling you to use it, so it’s effective” (MI; Ad 5). A female participant also alluded to perceived trust in doctors as credible figures: “people usually
trust doctors. So, in an audience where there’s concern of
unwanted pregnancy, [this might be effective]” (FI; Ad
5). Even when acknowledging doctors on ads may not be
actual doctors, participants still felt this imagery contributed to credibility: “[this ad shows HMC] is something
tested by doctors, adding the doctor to it, whether he’s an
actor or not, he likely is, it just makes it seem more credible” (MI; Ad 6). This suggests images of trustworthy
characters, such as doctors, may instill feelings of trust in
a potential HMC product.
Participants also mentioned informational messaging
as an additional contributor to trustworthiness. A male
participant expanded on this, suggesting the informational component of Ad 5 was most effective in instilling
trust:
This ad is most effective because it relates to me and how
serious I feel the problem is by portraying all the information.
It uses that lingo, so I feel that it’s something that’s been
approved by the FDA. . .everything feels right. (MI; Ad 5)

Trustworthiness was conceptualized by informational
messaging, echoing insights from focus groups and indicating the importance of implementing this strategy in
HMC marketing efforts. Participants responded most
positively to the combination of both informational messaging and the doctor character in Ad 5, demonstrating
these elements may work together to represent trustworthiness in an HMC ad.
Participants commented on the visual appeal of prototypes, with some preferring relatable or aspirational concepts, while others preferred the doctor image. One male
participant expressed favorable views on Ad 3, alluding
to the appeal of a relatable character: “[Ad 3] really
caught me. I like the words, and I can relate to it. . . it just

appeals to me” (MI; Ad 3). A female participant commented on Ad 4, the aspirational ad, suggesting the imagery successfully contextualized a potential situation in
which one might use HMC: “I think that picture is really
good, I feel like it gives a good context of things [related
to HMC]” (FI; Ad 4). Other participants echoed previous
perspectives, favoring the doctor image because “it
makes [the ad] seem more official, more professional. It’s
something you’d want to go talk to your doctor about”
(MI; Ad 5).
Participants also offered suggestions for HMC message concepts, most commonly related to representations
of how the product is used: “maybe a picture of a guy
rubbing [the gel on], like their hand on their shoulder. I
think a picture of him using the product [would be helpful]” (FI; Ad 3). A male participant further detailed this
would increase appeal:
I like [Ad 3] because it tells you, “just add one more step to
your routine.” You get out of the shower, trim your beard,
put on your moisturizer, do your hair. I just think [it should
also show] putting the gel on your shoulders. (MI; Ad 3)

Thus, message concepts audiences feel they can relate to
or trust, along with practical messaging or imagery meant
to increase agency in use may be best represented by an
impressionable character in an HMC ad. Figure 2 lays out
the prototypes in order of most to least preferred by participants, along with the frequencies of those who felt
positive, neutral, and negative sentiments toward each ad.

Discussion
This study utilized formative, audience-oriented research
to generate HMC marketing messages acceptable for a
college-aged population. Studies demonstrating the value
of employing formative research to inform message
development are limited (Martinez et al., 2012; Sundstrom
et al., 2015), especially in the context of contraceptive
and reproductive health products (Campo et al., 2013;
Colarossi et al., 2010; DeMaria et al., 2017; Sundstrom
et al., 2015, 2016). Using focus groups to gather initial
insights, then creating prototypes, and testing them in
follow-up interviews ensured participant narratives drove
the research process, increasing reliability (Colarossi
et al., 2010; Sundstrom et al., 2015). Understanding and
applying consumer wants and needs is valuable to also
instill trust, loyalty, and value co-creation.
Focus groups illuminated salient concepts for HMC
marketing, including humor, destigmatization, information, and credibility—supporting past contraceptive promotion research (Campo et al., 2013; Colarossi et al.,
2010; DeMaria et al., 2017; Sundstrom et al., 2015,
2016). Humor is often used with contraception, as most
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Figure 2. Prototypes by Preference.

individuals are knowledgeable of its benefits (Campo
et al., 2013). However, upon message creation and testing, the lightheartedness perpetuated by the humorous
message was not well-received, indicating the use of this
sentiment in the context of a novel contraceptive product
may not be as effective, and suggesting a key strategy for
HMC being developing trust and brand recognition
before presenting humorous messages to enhance effectiveness. Normalization was well-accepted (DeMaria
et al., 2017), further emphasizing the importance of representing real experiences in HMC messaging strategy.
Message testing confirmed destigmatization as effective
when represented as honest experiences, specifically
focused on normalizing HMC and painting it as a “smart
choice.” Destigmatizing messaging may work to counteract negative perceptions (i.e., difficulty accepting HMC,
potential feelings of emasculation, and negative perceptions) by normalizing HMC use (e.g., making the behavior popular), and drawing on authentic experiences to
better align with consumer values.
Participants felt informational messages offering credibility were most useful for promoting HMC, suggesting
information on ads is compelling to consumers (Sundstrom

et al., 2015), while credibility can significantly impact
uptake and correct use (Wagner et al., 2018). Participants
reinforced this strategy, primarily referring to this combination as instilling trust in a potential HMC product. As
credibility in ads is most influential when a recipient has
little to no information about a product (Munnukka et al.,
2016), understanding conceptualizations of credibility is
crucial for novel product messaging. Credibility is often
comprised of trustworthiness and expertise (Munnukka
et al., 2016), as it provides reassurance to those who may
be hesitant or fearful of adopting a new behavior. This
supports participant narratives surrounding partiality
toward the doctor image, as well as suggestions to present
step-by-step use instructions. Combining informational
messaging to increase agency in use with messaging concepts audiences feel they can relate to or trust may be
effective for marketing HMC.

Implications for Marketing Practice
Despite the commercial unavailability of HMC, findings
provide practical implications for health communication
practice within the context of novel health products. The
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example of HMC as a novel health product was wellpositioned for the current study because, as it is not yet
available, the baseline for past behavior or use is zero,
eliminating bias from experiences or extensive preconceived notions. The data reflected raw perspectives of the
target audience. For novel health products, the lack of
prior knowledge and use experience elucidates the utility
of infusing information and credibility messages in marketing strategy to better position the product as trustworthy among target consumers.
Our initial formative audience research findings
uncovered the importance of prioritizing humor, information, destigmatization, and credibility when developing
HMC messaging. However, as evidenced by message
prototype design and testing, understanding message
concepts alone may not be sufficient to ensure a successful campaign for HMC. Applying message concepts and
testing among college-aged male and female audience
segments revealed humor as ineffective without prior
brand loyalty and recognition, while sentiment and trustworthiness emerged as additional integral elements contributing to successful HMC messaging. For similar
novel health products or health behavior change efforts
among the college-aged audience, marketing strategy
should extend beyond testing message concepts and focus
on testing concrete messages gleaned from initial formative research to enhance message efficacy.
Results also provided a baseline of health and social
topics that would be critical to address when preparing a
college-aged population for future HMC acceptance and
uptake. Participants supported the idea of a potential male
option, with men desiring contraceptive autonomy and
women wanting to shoulder less of the contraceptive burden. Concerns about side effects, proper use, and safety
were prominent, along with social issues like normalization and destigmatization. This further emphasizes the
importance of education through health campaign efforts,
not only to dispel health outcome myths but also to the
social and cultural landscape among a college-aged
audience.

Limitations and Future Research
Focus groups and interviews allowed participants to provide robust consumer insights related to the potential
introduction of HMC. The iterative process of basing
message concepts and designs on formative research, creating, and testing contributed to study reliability
(Colarossi et al., 2010; Sundstrom et al., 2015). Findings
provide applicable first steps for marketers to consider
when promoting novel contraceptive products, such as
HMC. However, study limitations exist. Due to the nature
of qualitative research, generalizability to wider populations is limited. The sample also lacked racial/ethnic
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diversity, as a majority of participants self-identified as
White. Historically, communities of color were targeted
in novel contraceptive testing (Kusunoki et al., 2016),
which may affect how future messaging strategies are
designed; thus, the lack of diversity is a limitation. Results
around healthcare providers as a trustworthy source may
have also varied depending on a participant’s race/ethnicity, posing an additional limitation related to lack of sample diversity (Halbert et al., 2006). Despite emphasizing
the importance of confidentiality in focus groups, the
nature of focus groups poses a threat to open and honest
sharing within the group, potentially introducing social
desirability bias. In addition, the first author, who moderated the focus groups and conducted the interviews, is
female, which may have influenced, particularly male
participants, to offer more favorable responses.
However, through rapport building, the first author reassured participants that their honest responses would be
respected and kept confidential. Participants were also
recruited in a university setting, resulting in a convenience sample. Despite these limitations, this study
offers novel contributions to the contraceptive advertising and promotion research body, serving as the first
empirical study incorporating consumer insights to
design and test effective marketing messages to a novel
male contraceptive product before its availability.
Future research should test the utility of applying the
current methodology to a novel health product other
than HMC. Furthermore, future research should consider women’s impact on male contraception use in
addition to how male consumer habits may be impacted
overall by their partners. Consumer insights surrounding preferred marketing strategy for a novel contraceptive product, like HMC, should also be examined outside
of a university setting to better understand necessary
consumer segmentation.

Conclusion
This study sought to understand college-aged men’s and
women’s perceptions of effective marketing strategies
for an experimental HMC method. Consumer insights
provided a foundation for the creation of HMC message
prototypes and message testing identified elements participants responded most strongly to. Representation of a
relatable character, or drawing on authentic experiences,
aligned best with consumer values. In addition, practical
messaging or imagery may be an effective combination
for marketing a novel contraceptive product. Findings
provide a basis for understanding the placement of a
potential marketing campaign to effectively frame HMC
uptake as easy to use, safe, and popular while building
on peer norms and group acceptability among a collegeaged demographic. Healthcare providers and other
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practitioners can utilize these findings when engaging in
family planning conversations, interventions, and message development with patients and communities.
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